Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Midwifery ; 31(7): 678-84, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25931276

RESUMO

OBJECTIVE: to explore and describe how healthcare professionals in the Southern Region of Denmark experienced motivational interviewing as a communication method when working with pregnant women with obesity. DESIGN: a qualitative, descriptive study based on face-to-face interviews with 11 obstetric healthcare professionals working in a perinatal setting. METHODS: a thematic descriptive method was applied to semi-structured interviews. The healthcare professional's experiences were recorded verbatim during individual semi-structured qualitative interviews, transcribed, and analysed using a descriptive analysis methodology. FINDINGS: motivational interviewing was found to be a useful method when communicating with obese pregnant women. The method made the healthcare professionals more aware of their own communication style both when encountering pregnant women and in their interaction with colleagues. However, most of the healthcare professionals emphasised that time was crucial and they had to be dedicated to the motivational interviewing method. The healthcare professionals further stated that it enabled them to become more professional in their daily work and made some of them feel less 'burned out', 'powerless' and 'stressed' as they felt they had a communication method in handling difficult workloads. CONCLUSION: healthcare professionals experienced motivational interviewing to be a useful method when working perinatally. The motivational interviewing method permitted heightened awareness of the healthcare professionals communication method with the patients and increased their ability to handle a difficult workload. Overall, lack of time restricted the use of the motivational interviewing method on a daily basis.


Assuntos
Atitude do Pessoal de Saúde , Tocologia , Entrevista Motivacional , Obesidade/prevenção & controle , Complicações na Gravidez/prevenção & controle , Cuidado Pré-Natal , Adulto , Dinamarca , Feminino , Humanos , Capacitação em Serviço , Entrevistas como Assunto , Pessoa de Meia-Idade , Gravidez
2.
J Intellect Dev Disabil ; 31(3): 166-71, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16954095

RESUMO

BACKGROUND: It is known that women with Down syndrome can be fertile, but it is not known whether all women with Down syndrome are fertile or sub-fertile. The age at menopause for women with Down syndrome is lower compared to women without Down syndrome. METHOD: A cross-sectional study of 11 women was undertaken, in which the participating women had a blood sample taken and were also examined using transabdominal ultrasound scanning (ULS). RESULTS: Definite signs of ovulation were evident in 2 women; hormone values in 5 women showed that they were in the luteal phase of the menstrual cycle; 1 woman was anovulatory; and in 1 woman it was not possible to judge the time of the menstrual cycle. Two of the women were postmenopausal according to medical information, ultrasound examination and hormone values. CONCLUSIONS: Safe contraceptives should be considered and offered if women with Down syndrome are engaging in sexual relations. Early menopause (before the age of 40 years) and the possibility of hormonal replacement therapy should be kept in mind.


Assuntos
Climatério/genética , Síndrome de Down/genética , Menopausa Precoce/genética , Ciclo Menstrual/genética , Adulto , Climatério/sangue , Comorbidade , Estudos Transversais , Síndrome de Down/diagnóstico , Síndrome de Down/epidemiologia , Estradiol/sangue , Feminino , Hormônio Foliculoestimulante/sangue , Humanos , Infertilidade Feminina/sangue , Infertilidade Feminina/diagnóstico , Infertilidade Feminina/epidemiologia , Infertilidade Feminina/genética , Hormônio Luteinizante/sangue , Menopausa Precoce/sangue , Ciclo Menstrual/sangue , Progesterona/sangue , Valores de Referência , Estatística como Assunto , Ultrassonografia
3.
Prev Med ; 41(1): 321-7, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15917028

RESUMO

BACKGROUND: Smoking is the main preventable cause of lifestyle-related diseases and smoking cessation interventions have shown to be cost-effective. It is important to know the smoking habits and attitudes towards smoking among the hospital staff because of the impact the staff have on the patients. Two studies were conducted to attain this information. METHODS: This study analyzes the results of a survey conducted in the summer of 2001 and compares them to a similar study conducted in 1999. 970 anonymous questionnaires were distributed in 2001. RESULTS: The number of smokers among the staff has significantly decreased from 33% to 26% over the 2-year period. Those who do still smoke are less willing to quit and are reluctant to accept help to stop smoking. Fewer are bothered by passive smoking now compared to 1999 and approximately 2/3 of the responders do not find it acceptable to implement sanctions against the members of staff who break the prohibition. CONCLUSION: It is worth providing resources to smoking cessation intervention. The intensive preventive work carried out at the hospital may have resulted in significantly fewer smokers among the staff which again facilitate the staff's effort to help the patients stop smoking.


Assuntos
Atitude Frente a Saúde , Corpo Clínico Hospitalar/estatística & dados numéricos , Abandono do Hábito de Fumar/estatística & dados numéricos , Fumar/epidemiologia , Poluição por Fumaça de Tabaco/estatística & dados numéricos , Adulto , Fatores Etários , Atitude do Pessoal de Saúde , Estudos Transversais , Dinamarca/epidemiologia , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Recursos Humanos em Hospital/estatística & dados numéricos , Probabilidade , Medição de Risco , Fatores de Risco , Fatores Sexuais , Fumar/psicologia , Prevenção do Hábito de Fumar , Inquéritos e Questionários , Fatores de Tempo , Poluição por Fumaça de Tabaco/prevenção & controle , Local de Trabalho
5.
Contraception ; 71(2): 111-7, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15707560

RESUMO

OBJECTIVES: To evaluate the impact on lipid and carbohydrate variables of a combined one-third ethinyl estradiol (EE)/levonorgestrel (LNG) dose reduction in oral contraceptives. METHODS: In an open-label, randomized study, a dose-reduced oral contraceptive containing 20 microg EE and 100 microg LNG (20 EE/100 LNG) was compared with a reference preparation containing 30 microg EE and 150 microg LNG (30 EE/150 LNG). One-year data from 48 volunteers were obtained. RESULTS: We found a decrease of HDL2 cholesterol and increases of low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol and total triglycerides in both treatment groups from baseline to the 13th treatment cycle. Although for four of six variables, the changes in the 20 EE group were lower compared with the 30 EE group, none of the differences between the two treatments were statistically significant. The median values for the fasting levels of insulin, C-peptide and free fatty acids slightly increased or remained unchanged while the fasting glucose levels slightly decreased after 13 treatment cycles. While the glucose area under the curve (AUC) (0-3 h) was similar in both groups during the OGTT, the insulin AUC(0-3 h) was less increased in the 20 EE/100 LNG group compared with the 30 EE/150 LNG group. None of the differences between the treatment groups for any of the carbohydrate metabolism variables were statistically significant at any time point. Both study treatments were safe and well tolerated by the volunteers. CONCLUSION: Similar effects on the lipid and carbohydrate profiles were found for both preparations. The balanced one-third EE dose reduction in this new oral contraceptive caused slightly lower, but insignificant, changes in the lipid and carbohydrate variables compared with the reference treatment.


Assuntos
Metabolismo dos Carboidratos/efeitos dos fármacos , Anticoncepcionais Orais Combinados/farmacologia , Etinilestradiol/farmacologia , Levanogestrel/farmacologia , Metabolismo dos Lipídeos/efeitos dos fármacos , Adulto , Glicemia/metabolismo , Peptídeo C/sangue , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Anticoncepcionais Femininos/administração & dosagem , Anticoncepcionais Femininos/farmacologia , Anticoncepcionais Orais Combinados/administração & dosagem , Dinamarca , Relação Dose-Resposta a Droga , Etinilestradiol/administração & dosagem , Ácidos Graxos não Esterificados/sangue , Feminino , Humanos , Insulina/sangue , Levanogestrel/administração & dosagem , Estudos Prospectivos , Fatores de Tempo , Resultado do Tratamento , Triglicerídeos/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...